Dr Yolanda Surjan of Radvet presents her founder experience as part of Startup Stories a regular Three76 Hub event

Startup Stories - Dr Yolanda Surjan, RadVet

Thursday, 17 August 2017, 01:00 pm — Thursday, 17 August 2017, 02:00 pm


Location Three76 Hub, 376 Hunter St, Newcastle
Contact Three76@newcastle.edu.au

Yolanda surjan

Taking your research out of the cloistered halls of academia and into the real world is an experience filled with trepidation and not for the faint-hearted. But UON Academic, Dr Yolanda Surjan, is a woman of conviction. She knew her research had shown that human radiation treatment for cancer was translatable to animals, with great commercial potential.

The problem was, she didn’t know where to start to make that commercial leap. Fast forward 12 months and after applying and being accepted into CSIRO’s pre-accelerator program in 2016 she has not looked back. She’s pivoted, found traction and won the award for CSIRO Breakout Female Scientist. Her idea has found investment for a pilot and implementation across broader veterinary practise and has the great tagline of being ‘tested on humans first’.

Many startups have their foundation in university research – come along to Startup Stories this week to hear from the latest researcher joining an esteemed group of UON spinouts going places.

About Startup Stories

Startup Stories takes place every Thursday from 1pm at University of Newcastle's coworking space Three76 Hub on Hunter Street. Over BYO lunch, a startup founder talks candidly about their experience as an entrepreneur and business owner – the highs, the lows, the wins, the mistakes, the whole enchilada. Startup Stories provides real-life examples of the different stages of the startup journey, creating a forum for startups to share and learn but also for the community to see tangible evidence of entrepreneurship making a difference in our region.

Program Partners

UON is proud to be able to bring this event to you via the NSW State Government's Boosting Business Innovation Program funding.